Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CRON 
Cronos Group Inc (CRON)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/02/2025: CRON (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $2.12
1 Year Target Price $2.12
| 1 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -14.06% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/02/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 953.45M USD | Price to earnings Ratio 22.64 | 1Y Target Price 2.12 |
Price to earnings Ratio 22.64 | 1Y Target Price 2.12 | ||
Volume (30-day avg) 5 | Beta 1.06 | 52 Weeks Range 1.60 - 3.16 | Updated Date 12/1/2025 |
52 Weeks Range 1.60 - 3.16 | Updated Date 12/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.11 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-11-06 | When - | Estimate 0.02 | Actual 0.07 |
Profitability
Profit Margin 27.27% | Operating Margin (TTM) -13.83% |
Management Effectiveness
Return on Assets (TTM) -1.39% | Return on Equity (TTM) 3.67% |
Valuation
Trailing PE 22.64 | Forward PE - | Enterprise Value 113828116 | Price to Sales(TTM) 7.2 |
Enterprise Value 113828116 | Price to Sales(TTM) 7.2 | ||
Enterprise Value to Revenue 0.86 | Enterprise Value to EBITDA -1.42 | Shares Outstanding 382893267 | Shares Floating 202282513 |
Shares Outstanding 382893267 | Shares Floating 202282513 | ||
Percent Insiders 47.07 | Percent Institutions 16.08 |
Upturn AI SWOT
Cronos Group Inc
Company Overview
History and Background
Cronos Group Inc. was founded in 2012 and went public in 2018. Initially, it focused on the production and sale of medical cannabis in Canada. Over time, it expanded its operations internationally and diversified into recreational cannabis and hemp-derived CBD products.
Core Business Areas
- Cultivation and Production: Cultivation of cannabis flower and production of cannabis extracts and concentrates.
- Branded Product Sales: Sale of cannabis products under various brands, including Spinach, PEACE NATURALS, Lord Jones, and Happy Dance.
- International Expansion: Developing cannabis products and markets outside of the United States and Canada.
Leadership and Structure
Cronos Group Inc. is led by a management team with experience in the cannabis industry and consumer packaged goods. The organizational structure includes departments for cultivation, production, sales, marketing, research and development, and finance.
Top Products and Market Share
Key Offerings
- Spinach: A Canadian cannabis brand offering a range of cannabis flower, pre-rolls, edibles, and vaporizers. Competitors include Canopy Growth, Aurora Cannabis, and Tilray.
- PEACE NATURALS: A brand focused on medical cannabis products, offering cannabis oils and dried flower for therapeutic use. Competitors include other medical cannabis brands like Aphria and MedReleaf.
- Lord Jones: A premium CBD brand offering skincare, wellness, and confectionery products. Competitors include Charlotte's Web and CBDistillery.
- Happy Dance: A CBD skincare brand co-founded with Kristen Bell, offering bath bombs and other personal care products. Competitors include Kana and Prima.
Market Dynamics
Industry Overview
The cannabis industry is experiencing rapid growth, driven by increasing legalization and consumer acceptance of cannabis products. The market is becoming more competitive, with new entrants and established players vying for market share.
Positioning
Cronos Group Inc. is positioned as a global cannabis company with a focus on branded products and international expansion. Its competitive advantages include its strong brand portfolio, strategic partnerships, and focus on research and development.
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions USD in the coming years. Cronos Group Inc. is positioned to capture a portion of this market through its diverse product offerings and international expansion strategy.
Upturn SWOT Analysis
Strengths
- Strong brand portfolio
- Strategic partnerships (e.g., Altria)
- Focus on research and development
- Global presence
Weaknesses
- History of net losses
- Relatively small market share compared to key competitors
- Regulatory uncertainties in various markets
- Cash Burn
Opportunities
- Further legalization of cannabis in new markets
- Expansion of product offerings into new categories
- Increased consumer awareness and acceptance of cannabis
- Growth in the CBD market
Threats
- Intense competition from other cannabis companies
- Changing regulatory landscape
- Fluctuations in cannabis prices
- Potential for oversupply in the market
Competitors and Market Share
Key Competitors
- TLRY
- CGC
- ACB
- SMG
Competitive Landscape
Cronos Group Inc. faces intense competition from other cannabis companies. Its advantages include its strong brand portfolio and strategic partnerships, while its disadvantages include its relatively small market share and profitability challenges.
Major Acquisitions
Lord Jones
- Year: 2019
- Acquisition Price (USD millions): 300
- Strategic Rationale: To expand into the CBD market and leverage Lord Jones' premium brand reputation.
Growth Trajectory and Initiatives
Historical Growth: Cronos Group Inc.'s historical growth has been characterized by rapid expansion and increasing revenue. However, the company has also experienced significant losses.
Future Projections: Future projections for Cronos Group Inc. are subject to various factors, including regulatory changes, market conditions, and competitive pressures. Analyst estimates vary widely.
Recent Initiatives: Recent strategic initiatives include investments in research and development, expansion into new markets, and the introduction of new branded products.
Summary
Cronos Group Inc. is a global cannabis company with a diversified product portfolio and strategic partnerships. The company faces challenges in achieving profitability and gaining market share in a competitive landscape. However, its strong brands and international expansion efforts position it for future growth. Regulatory hurdles and price fluctuations are major considerations for future outlooks.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Filings
- Industry Reports
- Analyst Estimates
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. The data and analysis are based on publicly available information and may not be complete or accurate. Market share estimates are approximations. Financial data may be delayed.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cronos Group Inc
Exchange NASDAQ | Headquaters Stayner, ON, Canada | ||
IPO Launch date 2016-07-12 | President, CEO & Chairman Mr. Michael Ryan Gorenstein J.D. | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 459 | Website https://thecronosgroup.com |
Full time employees 459 | Website https://thecronosgroup.com | ||
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.